Barry Cherney

Latest from Barry Cherney

Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and Analytics
CMC Forums
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and AnalyticsNext-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and Analytics
byAnthony Mire-Sluis, Sarah Kennettand 8 more
Dec 17, 2020
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream Strategies
CMC Forums
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream StrategiesNext-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream Strategies
byAnthony Mire-Sluis, Sarah Kennettand 7 more
Oct 29, 2020

All from Barry Cherney

Myths, Risks, and Best Practices: Production Cell Line Development and Control of Product Consistency During Cell Cultivation
Cell Line Development
Myths, Risks, and Best Practices: Production Cell Line Development and Control of Product Consistency During Cell Cultivation
Myths, Risks, and Best Practices: Production Cell Line Development and Control of Product Consistency During Cell Cultivation
Sep 19, 2018
+3
byBarry Cherney, Dieter Schmalzingand 3 more
eBook: Production Cell-Line Development and Control of Product Consistency During Cultivation — Myths, Risks, and Best Practices
Cell Line Development
eBook: Production Cell-Line Development and Control of Product Consistency During Cultivation — Myths, Risks, and Best Practices
eBook: Production Cell-Line Development and Control of Product Consistency During Cultivation — Myths, Risks, and Best Practices
Apr 30, 2018
+3
byBarry Cherney, Dieter Schmalzingand 3 more
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
CMC Forums
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
Apr 12, 2016
+18
byCheryl Scott, Siddharth J. Advant, PhDand 18 more
Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices logo in a gray background | Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices
Assays
Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices
Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices
Mar 1, 2014
+3
byAnthony Mire- Sluis, Nadine Ritterand 3 more
Analysis and Immunogenic Potential of Aggregates and Particles logo in a gray background | Analysis and Immunogenic Potential of Aggregates and Particles
QA/QC
Analysis and Immunogenic Potential of Aggregates and Particles
Analysis and Immunogenic Potential of Aggregates and Particles
Dec 1, 2011
+6
byAnthony Mire- Sluis, Barry Cherneyand 6 more
Analysis and Immunogenic Potential of Aggregates and Particles logo in a gray background | Analysis and Immunogenic Potential of Aggregates and Particles
QA/QC
Analysis and Immunogenic Potential of Aggregates and Particles November 2011
Analysis and Immunogenic Potential of Aggregates and Particles November 2011
Nov 1, 2011
+6
byAnthony Mire- Sluis, Barry Cherneyand 6 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024